National Bank of Canada’s GSK GSK Stock Holding History

National Bank of Canada’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.46M	Buy	98,990 +31,302	+46%	+$1.7M	﹤0.01%	835
2025 Q4	$3.32M	Buy	67,688 +4,334	+7%	+$202K	﹤0.01%	967
2025 Q3	$2.73M	Sell	63,354 -3,598	-5%	-$141K	﹤0.01%	1019
2025 Q2	$2.57M	Buy	66,952 +4,353	+7%	+$166K	﹤0.01%	1091
2025 Q1	$2.43M	Sell	62,599 -1,766	-3%	-$64.7K	﹤0.01%	1021
2024 Q4	$2.18M	Sell	64,365 -2,709	-4%	-$97.5K	﹤0.01%	1149
2024 Q3	$2.74M	Sell	67,074 -7,259	-10%	-$297K	﹤0.01%	954
2024 Q2	$2.85M	Sell	74,333 -672	-0.9%	-$28.3K	﹤0.01%	870
2024 Q1	$3.38M	Buy	75,005 +2,602	+4%	+$107K	0.01%	908
2023 Q4	$2.72M	Sell	72,403 -107,220	-60%	-$3.85M	﹤0.01%	936
2023 Q3	$6.45M	Sell	179,623 -138,316	-44%	-$4.91M	0.01%	732
2023 Q2	$11.2M	Sell	317,939 -83,141	-21%	-$2.98M	0.02%	528
2023 Q1	$14.4M	Sell	401,080 -3,475	-0.9%	-$122K	0.04%	348
2022 Q4	$14.2M	Sell	404,555 -148,153	-27%	-$4.93M	0.04%	343
2022 Q3	$16.6M	Sell	552,708 -14,503	-3%	-$550K	0.09%	255
2022 Q2	$31M	Buy	567,211 +41,775	+8%	+$2.31M	0.14%	159
2022 Q1	$29.6M	Buy	525,436 +354,239	+207%	+$19.2M	0.09%	211
2021 Q4	$9.44M	Buy	+171,197	New	+$8.91M	0.03%	402

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

National Bank of Canada's GSK Position: Q1 2026 in Review

National Bank of Canada increased its GSK (GSK) stake by 46% in Q1 2026, buying an estimated $1.7M and bringing the position to 98,990 shares worth $5.46M. The position accounts for ﹤0.01% of the portfolio, ranked #835.

National Bank of Canada first reported a position in GSK in Q4 2021 and has held it in 18 quarters since. The position peaked at $31M in Q2 2022. 1,033 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

National Bank of Canada held 98,990 shares of GSK worth $5.46M as of Q1 2026.
National Bank of Canada bought 31,302 GSK shares in Q1 2026, an estimated $1.7M.
GSK made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #835 holding.
National Bank of Canada first reported a position in GSK in Q4 2021 and has held it in 18 quarters since.
National Bank of Canada's GSK position peaked at $31M in Q2 2022.
1,033 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.